Literature DB >> 12568441

Cancer statistics, 2003.

Ahmedin Jemal1, Taylor Murray, Alicia Samuels, Asma Ghafoor, Elizabeth Ward, Michael J Thun.   

Abstract

Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year, and compiles the most recent data on cancer incidence, mortality, and survival by using incidence data from the National Cancer Institute (NCI) and mortality data from the National Center for Health Statistics (NCHS). Incidence and death rates are age adjusted to the 2000 US standard population. In the year 2003, we estimate that 1,334,100 new cases of cancer will be diagnosed, and 556,500 people will die from cancer in the United States. Age-adjusted cancer death rates declined in both males and females in the 1990s, though the magnitude of decline is substantially higher in males than in females. In contrast, incidence rates continued to increase in females while stabilizing in males. African-American males showed the largest decline for mortality. However, African Americans still carry the highest burden of cancer with diagnosis of cancer at a later stage and poorer survival within each stage compared with Whites. In spite of the continued decline in cancer death rates in the most recent time period, the total number of recorded cancer deaths in the United States continues to increase slightly due to the aging and expanding population.

Entities:  

Mesh:

Year:  2003        PMID: 12568441     DOI: 10.3322/canjclin.53.1.5

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  614 in total

1.  Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.

Authors:  Yingwen Liu; Yanghui Bi; Jia Lin; Lei Cao; Bing He; Zhi Zhang; Yongping Cui; Xuemei Zhang
Journal:  Tumour Biol       Date:  2014-11-15

2.  Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.

Authors:  Milica Kontic; Jelena Stojsic; Dragana Jovanovic; Vera Bunjevacki; Simona Ognjanovic; Jacquelyn Kuriger; Susan Puumala; Heather H Nelson
Journal:  Clin Lung Cancer       Date:  2011-12-13       Impact factor: 4.785

3.  Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors.

Authors:  Kathryn H Schmitz; Andrea B Troxel; Andrea Cheville; Lorita L Grant; Cathy J Bryan; Cynthia R Gross; Leslie A Lytle; Rehana L Ahmed
Journal:  Contemp Clin Trials       Date:  2009-01-08       Impact factor: 2.226

4.  Chemoradiotherapy in the management of locally advanced squamous cell carcinoma esophagus: is surgical resection required?

Authors:  Sheh Rawat; Gaurav Kumar; Anjali Kakria; Manoj Kumar Sharma; Deepika Chauhan
Journal:  J Gastrointest Cancer       Date:  2013-09

Review 5.  Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

Authors:  H G Smeenk; T C K Tran; J Erdmann; C H J van Eijck; J Jeekel
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

6.  Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer.

Authors:  Seok Jin Kim; Zahid N Rabbani; Fan Dong; Robin T Vollmer; Ernst-Gilbert Schreiber; Mark W Dewhirst; Zeljko Vujaskovic; Michael J Kelley
Journal:  Med Oncol       Date:  2009-02-24       Impact factor: 3.064

Review 7.  Communication and intimacy-enhancing interventions for men diagnosed with prostate cancer and their partners.

Authors:  Christian J Nelson; Joslyn Kenowitz
Journal:  J Sex Med       Date:  2013-02       Impact factor: 3.802

8.  Detection of CK20mRNA in peripheral blood of pancreatic cancer and its clinical significance.

Authors:  Yun-Li Zhang; Jian-Guo Feng; Jian-Min Gou; Li-Xin Zhou; Ping Wang
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

9.  Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.

Authors:  Nehad M Alajez; Jan Schmielau; Mark D Alter; Michael Cascio; Olivera J Finn
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

Review 10.  Pancreatic cancer - a continuing challenge in oncology.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.